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Abstract
Background: A new model of care is required to meet the changing needs of people living with HIV (PLWH),
particularly in low and middle-income countries, where prevalence is highest. We evaluated a palliative care
intervention for PLWH in Mombasa, Kenya. Although we found no effect on pain (primary outcome), there was
a positive effect on mental health (secondary outcome) in the intervention group. To inform replication and
implementation, we have determined the active ingredients of the intervention and their mechanisms of action.
Methods: We conducted a randomised controlled trial (RCT) with qualitative exit interviews in HIV clinic attenders.
The intervention was delivered over 5 months, with a minimum of 7 clinical contacts. Longitudinal quantitative
data on components of care received were analysed using area under the curve and logistic regression. Qualitative
data were analysed using inductive and deductive thematic analysis.
Results: Quantitative data analysis identified that intervention patients received more weak opioid, laxatives, discussion
about spiritual worries, emotional support from staff for themselves and their families, time to talk about worries,
discussion about future and planning ahead. Qualitative data analysis found that patients reported that having
time to talk, appropriate pain medication and effective health education was of therapeutic value for their
psychological well-being. Integration of mixed method findings suggest that positive effect in quantitative
measures of mental health and well-being are attributable to the active ingredients of: appropriate medication,
effective health education and counselling, and having time to talk in clinical encounters. Mechanisms of action
include symptom relief, improved understanding of illness and treatment, and support focused on articulated
concerns.
Conclusions: Routine care must provide opportunities and means for existing clinical staff to make routine
appointments more person-centred. This approach enabled staff to identify and manage multidimensional
problems and provide tailored health education and counselling.
Trial registration: ClinicalTrials.gov (NCT01608802). Registered 12th May 2012.
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Background
Due to treatment advances, HIV has been transformed
from an acute infection to a chronic condition for those
with access to antiretroviral therapy (ART) [1]. However,
in resource-constrained settings where the disease bur-
den is greatest, a paradigm shift is needed for health sys-
tems and providers to provide an adequate, sustainable
response [2]. The current model of HIV care is delivered
in overstretched systems with weak infrastructure and
high numbers of patients, and these challenges have
been associated with attrition from ART programmes
[3]. Due to the efforts made to meet the UNAIDS
90–90–90 targets, these problems will be exacerbated by
the projected increases in people living with HIV
(PLWH) accessing ART [4].
HIV outpatients in low and middle income settings
have a high burden of psychosocial and physical prob-
lems [5], evident from the point of diagnosis [6], and
persisting alongside ART use [7]. These problems nega-
tively affect patients’ ability to maintain ART adherence
and their engagement with and retention in care [8],
which potentially leads to viral resistance and its associ-
ated clinical and public health implications. A potentially
appropriate model to address these challenges is pallia-
tive care. This holistic, person-centred approach has
been shown to effectively reduce distress in people living
with HIV, but the evidence primarily relates to the end
of life, predates the development of highly active ART,
and is from high income countries [9].
Palliative care for PLWH is a complex intervention,
and therefore evaluation should not focus only on out-
comes, but also on process data [10, 11]. Identifying the
active ingredients of an intervention is key to under-
standing the causal mechanisms affecting observable
outcomes, the extent to which evaluation findings can
be extrapolated to other contexts, and which compo-
nents of an intervention should be replicated to achieve
its benefits [10, 11]. We aimed to identify the active
ingredients and mechanisms of action of a nurse-led pal-
liative care intervention for PLWH, in the context of a
randomised controlled trial (RCT) of the intervention in
Kenya [12, 13].
Methods
Study design
We conducted a parallel, two-arm, pragmatic open-label
RCT with qualitative exit interviews [14]. The RCT
found that, compared to standard care, a nurse-led pal-
liative care intervention was of benefit in terms of the
mental health dimension of quality of life, psychiatric
morbidity and psychosocial problems, but not physical
health [13]. During the trial, we conducted a mixed
methods evaluation to determine how these effects were
achieved, by identifying active ingredients of the
intervention and their mechanisms of action. We report
the results here. The methodology of the RCT, details of
the intervention and trial findings are reported
elsewhere [12–14]. The trial was registered with
ClinicalTrials.gov (NCT01608802).
PLWH at an HIV clinic in Mombasa, Kenya, were
screened according to the following eligibility criteria:
adults on ART for at least 1 month, with a pain or symp-
tom score of 3–5 (from a possible range of 0 (best) to 5
(worst)) on the African Palliative Care Association
Palliative Outcome Scale (APOS) [15, 16]. Exclusion cri-
teria were pain and symptoms caused entirely by an
acute problem (duration <2 weeks), receiving ART for
prevention of mother-to-child transmission of HIV, and
not speaking Swahili or English. Following baseline data
collection, participants were block-randomised to either
intervention or control. The trial was un-blinded to partic-
ipants and researchers, but blinded to the data analyst.
Qualitative exit interviews were conducted with 20
participants from the intervention group. A sample of
20 was judged as likely to achieve thematic saturation
while allowing in-depth interrogation [17]. Sampling was
in line with an explanatory sequential mixed methods
design: we purposively selected participants to achieve a
maximum variation sample based on individuals’ quanti-
tative clinical response to the intervention. Clinical
response was measured using a locally-validated,
disease-specific measure of quality of life, the Mental
Health Summary Score (MHSS) from the Medical
Outcomes Study-HIV (MOS-HIV), in which a change of
10 points across a scale of 100 is considered clinically
significant [18]. Participants were classed as “improving”
if the study exit MHSS was more than 10 points higher
than the baseline score, “deteriorating” if the MHSS at
study exit was more than 10 points lower than the base-
line score, and “static” otherwise.
Data collection and outcome variable definition
Each measure was used to collect quantitative data at five
monthly interviews throughout the study period of
4 months (0,1, 2, 3, 4 months). We used an adapted ver-
sion of the 22-item version of the Client Services Receipt
Inventory (CSRI) [19, 20] to measure the components of
care patients received during the study period. This gener-
ated a binary outcome of whether a component of care
had been received during the study period or not. We cre-
ated a variable to indicate whether the client had ever re-
ceived each component of care throughout the study. This
variable was used in analysis. As described, we used the
mental health sub scale of the MOS-HIV (MHSS) [18] to
measure clinical response to the intervention. The MOS-
HIV is a 35 item questionnaire that has been culturally
adapted to African settings and HIV populations [21–23].
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The same researcher who collected the quantitative
data conducted qualitative interviews. Interviews were
conducted between two to 6 months after exiting the
trial, in a private location in the participant’s language of
choice – Swahili or English – and digitally recorded.
The topic guide explored physical, psychological, social
and spiritual aspects of participants’ experiences of living
with HIV before, during and after the intervention, and
their experiences of the intervention. Participants were
also shown a line graph of their psychological well-being
throughout the study, measured at five time points at
monthly intervals (T0-T4) using the MOS-HIV MHSS.
This was used to prompt discussion about their experi-
ences during the study. If they could remember, they
were asked what was happening when their well-being
visibly changed on the graph. Experienced translators
transcribed the interviews verbatim and, where needed,
translated them into English. The translations were
quality-checked against the interview recordings by the
bilingual interviewer.
The intervention
Two experienced HIV clinic nurses employed by the
ART clinic received 2 weeks’ full-time palliative care
training. To enhance the person-centredness of care, the
nurses used an assessment and care plan addressing pa-
tients’ physical, psychological, social and spiritual prob-
lems. Complex cases (e.g. refractory pain) were referred
to specialist palliative care. An experienced local hospice
nurse provided the nurses with weekly supervision and
mentoring.
In addition to usual care, patients in the intervention
arm met the trained nurse immediately following base-
line interview and allocation, then at 2 weeks, 4 weeks
and three subsequent monthly appointments.
Standard care
Patients randomly allocated to the control arm contin-
ued to receive usual care from the HIV clinic, which
consisted of monthly clinical appointments.
Ethics
The study was approved by King’s College London
Research Ethics Committee (BDM/10/11–31) and the
Kenyan Medical Research Institute (KEMRI/RES/7/3/1).
All participants gave written informed consent.
Analysis
To determine and explore the active ingredients of the
intervention and their mechanisms of action, quantita-
tive and qualitative data were analysed separately subse-
quent to integration. Each was given equal importance
during the analysis.
Quantitative data analysis
Analysis followed the intention to treat approach as set
out in the analysis plan in the published trial protocol
[14]. P values were two-tailed and an alpha level of 0.05
was used to assess statistical significance. Single missing
items were imputed using horizontal mean method and
last value carried forward [24]. All quantitative analyses
were conducted using STATA version 10. The quantita-
tive data were analysed to detect differences in compo-
nents of care received by the intervention and control
groups, and to identify associations between components
of care and improvement in mental health in the inter-
vention group. A Bonferroni correction for the 22 tests
to be performed during this analysis indicated that a
threshold for significance of 0.002 would be a conserva-
tive indication of a statistically significant association.
However, because of concerns that use of Bonferroni
corrections leads to increased type II errors, a less con-
servative threshold of p ≤ 0.01 was used as a threshold
for statistical significance [25].
Differences between palliative care and standard care
Using the CSRI data, a graph displaying the components
of care received in the palliative care and standard care
groups was created for visual analysis. Next, chi square
tests were performed to identify any significant differ-
ences in care components received by the two trial arms.
Components of the intervention associated with
improvement
An individual-level summary statistic of longitudinal
psychological well-being was created by estimating the
area under the curve (AUC) of the MHSS of each par-
ticipant over time. The variable had a non-parametric
distribution which violated assumptions of many statis-
tical tests such as simple or quantile regression. There-
fore we recoded it into a binary variable, which we used
as the outcome for univariate logistic regression analyses
to test the association between psychological well-being
over time and receipt of each component of care (the
explanatory variables). We created this binary variable
using the median for the whole group (n = 114). This
median was not significant from a clinical point of view,
but it was used to maximise the size of subgroups and
minimise confidence intervals in logistic regression.
Qualitative data analysis
To identify and explore aspects of the intervention de-
scribed by participants as therapeutic, interview tran-
scripts were analysed in NVIVO 10 using thematic
analysis [26]. After familiarisation with the data, themes
were generated through a combination of deductive cod-
ing - based on our aim of identifying the active ingredi-
ents of the intervention and their mechanisms of action
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- and inductive coding to capture additional themes aris-
ing. A hierarchy of major themes and sub-themes was
created based on salience and conceptual coherence.
The preliminary coding frame created by KL was
reviewed, discussed and refined by the project team to
ensure conceptual integrity, prior to application of the
final coding frame to all transcripts (KL). To explore
barriers to effectiveness of the intervention, deviant case
analysis focused on qualitative data from the participants
who remained static (n = 5) and the one participant in
the intervention arm who deteriorated. A narrative ac-
count of the findings was drafted (KL, LS, RH) and re-
fined with input from the project team.
Results
Sample characteristics for the quantitative component of
the study are presented in Table 1. Of the 2070 patients
screened, 16% were eligible for inclusion into the trial, of
whom 44.3% agreed to participate [12].
The sample was predominantly female (81%), with a
mean age of 39 years, and a median of three financial
dependents (Table 1).
Quantitative findings
Differences between palliative care and standard care
A visual comparison of the differences in the compo-
nents of care received by participants in the two arms is
depicted in Fig. 1.
Of the 22 care components in the CSRI, the propor-
tion of participants in the intervention arm who received
each component at least once during the study period
was significantly higher for: discussion about spiritual
worries (X2 = 24·1 p < 0·001); emotional support from
staff (Fisher’s exact p < 0·001); time to talk to staff about
worries (Fisher’s exact p < 0·001); emotional support for
family (Fisher’s exact p < 0·001); weak opioids (X2 = 21.9
p < 0·001); discussion about the future (X2 = 24.6 p < 0·01);
constipation medication (X2 = 4.36 p = 0·04); and support
for the family in planning for the future (X2 = 22.9
p < 0·001) (Table 2).
Components of the intervention associated with
improvement
Almost all participants reported receiving emotional
support from staff (100%), ART adherence counselling
(98%), time to talk to staff about worries (98%), discus-
sion with staff about pain (100%) and discussion about
physical symptoms (100%). Due to the lack of variation,
analysis of these variables was not possible.
The median AUC estimate was 210.2 (IQR
186.6–230.0) for the 114 participants who had more
than 1 observation. It was recoded into a binary variable
with scores below the median indicating low MHSS over
time. Among intervention arm participants the median
AUC estimate was 216.1 (IQR 147.2–261.3). All inter-
vention participants who received discussions about
their spiritual worries, non-opioid analgesia and anti-
emetics reported levels of psychological well-being
higher than the median score. All participants who
received morphine reported levels of psychological well-
being lower than the median score. There was insuffi-
cient variation to produce a valid odds ratio for these
exposure variables. No other components of care were
associated with psychological well-being over time.
Qualitative findings
The qualitative sample was predominately female (17/
20), with a median of four financial dependants and low
levels of education (Table 3). All trial participants invited
for qualitative interview agreed. The mean time between
study exit and interview was 4.2 months.
Components of the intervention reported to be therapeutic
Three active ingredients were identified through analysis
of the qualitative data: i) appropriate medication, ii)
health education and counselling, and iii) having time to
talk. Associated mechanisms of action were symptom
Table 1 Characteristics of the TOPCare study sample
Entire sample
(n = 120)
Control
(n = 60)
Intervention
(n = 60)
Female n(%) 97 (81) 49 (82) 48 (80)
Mean age in years
(sd, range)
39
(8·9, 22–64)
40·5
(9·2, 22–64)
38·3
(8·2, 23–60)
Has a partner n (% yes) 76 (63) 36 (60) 40 (66·7)
Median no. children (IQR) 2 (1–4) 2.5 (1–4) 2 (1–4)
Median no. financial
dependents (IQR)
3 (2–5) 4 (3–5·5) 3 (2–5)
Education n
Never attended 10 6 4
<4 yrs. of school 3 1 2
Primary 76 35 41
Secondary 27 17 10
Diploma 4 1 3
Median years since
HIV diagnosis (IQR)
3·5 (1·3–5·2) 4·7
(2·4–5·7)
2·6 (0·9–4·4)
Median years on ART (IQR) 2·5 (0·8–4·2) 3·0
(1·6–5·0)
1·6 (0·4–3·5)
Median CD4 count
(cells/mm3, IQR)
358
(223–506)
343
(209–558)
359
(247–490)
Response to the
intervention: n (%)
(n = 116) (n = 60) (n = 54)
Clinically significant improvement on MOS-HIV
MHSS 63 (55) 31 (52) 31 (57)
Static 51 (45) 29 (48) 22 (41)
Deteriorated 1 (0.8) 0 (0) 1 (1.9)
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relief and improved function; improved insight and un-
derstanding; and articulated concerns and focussed sup-
port respectively.
Appropriate medication
Long-standing pain was resolved through access to ap-
propriate medication – weak opioids. Relief of physical
pain and distress contributed to an overall improvement
in well-being, and a return to previous levels of physical
and social function:
Whenever you found me to be sick, you got me the
required medication free of charge. That helped me
and kept me going for a long time… I started to feel
like I had resurrected. I felt like I’d come out of the
grave. ID125, female, 30 years, intervention
The benefit of appropriate medication was enhanced by
receiving health education and counselling:
I was distressed but I came here and was put under
medication, got better and went on well with my
work… I was helped with guidance, counselling on
the importance of sticking to medication… and I got
healed. ID 132, female, 45 years,
Mechanism of action: Symptom relief and improved function
Improved physical health meant participants could in-
creasingly care for themselves, earn a living and provide
for their dependants. This alleviated stress and contrib-
uted towards their positive self-image:
The pain eased because of the drugs that I took…
I can now move around, I can go to work and
I can do anything… That was the most important
thing:…my legs got well again and I started
working, I felt like a normal human being. ID 123,
male, 44 years
Health education and counselling
The health education and counselling provided com-
prised advice on how to live with an HIV diagnosis in a
positive way, including guidance on how to reduce sex-
ual transmission, manage disclosure to the community
and family, and cope with discrimination:
What benefited me most was the guidance on how to
live positively, commitment to church and being
prayerful. That I should always pray when faced with
difficulty, eat well, and I will have a long life. ID 132,
female, 45 years
Together with the study nurses, the participants were
able to identify and address substantial unmet health
education needs:
[My health] kept on improving because there were
many things that I had not known about that the
nurses taught me. ID 120, female, 36 years
Mechanism of action: Improved insight and understanding
Despite a median of 2·42 years on ART, participants de-
scribed gaps in their knowledge about treatment. In-
creased insight and understanding helped participants
take their medications as prescribed and make healthy
decisions:
The advice that you gave me really supported me.
I started thinking positively about my life and
believed that I could have a long life. ID 110,
female, 28 years
Fig. 1 Comparison of components of care received by participants allocated to the intervention and control study arms
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Access to the information needed to adequately self-care
was associated with the alleviation of depressive
symptoms:
I was in depressive moods, but later, owing to the
constant guidance you gave to me and my realisation
of the worthiness thereof, I started getting committed
in my mind and adhering to your instructions. ID 106,
female, 39 years
Having time to talk
The third active ingredient was having time to talk. The
clinic reported that an appointment in standard care
took less than 8 min, compared with approximately
45 min in the intervention appointments; the qualitative
data reflected this. In their meetings with the interven-
tion nurses, participants had time dedicated to talking
through their problems and concerns, and help articulat-
ing their needs:
I am better because I was listened to; I was helped.
I was given advice, and so I left with something. ID
108, female, 37 years
The time the participants had with study nurses com-
pared favourably with their experience of usual care: in
the clinic, a higher patient: staff ratio unavoidably meant
reduced contact time:
Here, we have more time with [the nurses]; they will
not see you in a hurry like the other place [standard
care clinic], because there are other people waiting.
Here you will be seen; you will explain your problem.
ID 108, female, 37 years
Table 3 Characteristics of intervention arm qualitative sample
(n = 20)
Variable Qualitative sample
(n = 20)
Female n (%) 17 (85)
Mean age in years (sd, range) 39·5 (6·75, 28–54)
Has a partner n (% yes) 12 (60)
Median number of children (IQR) 2 (2–3)
Median number of financial dependents (IQR) 3 (2–4)
Education attainment n (%)
None 2 (10)
4 years or less 2 (10)
Primary education 10 (50)
Secondary education 6 (30)
Diploma 0
Median years since HIV diagnosis (IQR) 3.8 (1.2–5.0)
Median years on ART (IQR) 2.8 (1.1–4.6)
Median CD4 count (cells/mm3, IQR) 341 (203–513)
Change in MOS-HIV MHSS over time:
Clinically significant improvement 14 (70)
Static 5 (25)
Deteriorated 1 (5)
Table 2 Numbers and percentage of participants receiving
components of care at least once during 4 months of follow up
by study arm
Service Control %
(n)
Intervention %
(n)
X2 test
and p value
Visit from spiritual leader 63·3 (38) 68·3 (41) X2 = 0·33
p = 0·56
Discussion about spiritual
worries
57 (34) 95 (57) X2 = 24·1
p < 0·001
Prayer with staff 12 (7) 25 (15) X2 = 3·56
p = 0·06
Emotional support
from staff
80 (49) 100 (60) Fisher’s exact
p < 0·001
ART adherence counselling 92 (55) 98 (59) Fisher’s exact
p = 0·21
Time to talk to staff
about worries
80 (48) 98 (59) Fisher’s exact
p < 0·001
Emotional support
for family
55 (33) 98 (59) Fisher’s exact
p < 0·001
Discussion about pain 97 (58) 100 (60) Fisher’s exact
p = 0·50
Discussion about
symptoms
98 (59) 100 (60) Fisher’s exact
p = 1·00
Non-opioid –
paracetamol
100 (60) 98 (59) Fisher’s exact
p = 1·00
Weak opioid – codeine 18 (11) 60 (36) X2 = 21·9
p < 0·001
Strong opioid – morphine 0 (0) 5 (3) Fisher’s exact
p = 0·24
Help with breathing
problems
83 (50) 75 (45) X2 = 1·26
p = 0·26
Anxiety medication 80 (48) 67 (40) X2 = 2·72
p = 0·10
Nausea medication 88 (53) 88 (53) X2 = 0·00
p = 1·00
Skin disorder medication 48 (29) 57 (34) X2 = 0·84
p = 0·36
Diarrhoea medication 18 (11) 22 (13) X2 = 0·21
p = 0·65
Constipation medication 12 (7) 27 (16) X2 = 4·36
p = 0·04
Discussion about future 22 (13) 67 (40) X2 = 24·6
p < 0·01
Planning ahead for family 22 (13) 65 (39) X2 = 22·9
p < 0·001
Nutrition support 18 (30) 18 (30) X2 = 0·00
p = 1·00
Financial support 7 (4) 5 (3) Fisher’s exact
p = 1·00
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Mechanism of action: Articulated concerns and focussed
support
The increased time to talk in the appointments with study
nurses meant participants’ concerns were more clearly ar-
ticulated and the nurses gained a greater understanding of
their problems than in the standard care clinic. Advice
and care planning could therefore focus on effectively ad-
dressing the root causes of their primary concerns:
There is a difference, because here you have a lot
of time to be with the doctor, to talk to him/her
and to have them instruct you. But on the other side
[in the standard care clinic], not that the nurses are
unwilling, but you personally feel… “Ah there are
others who are waiting to come in”. So you may be
having issues that you’d want addressed but you feel,
“Ah, I’ll raise when I come next time”. But here you
feel free to ask anything, without any problem. ID 120,
female, 36 years,
Because they felt listened to, participants’ interactions
with staff were reportedly more fruitful, and their emo-
tional, social and educational needs were addressed in a
targeted way, benefitting their physical and psychological
well-being.
Deviant case analysis: Barriers to effectiveness
Intervention arm participants whose quality of life
remained static or deteriorated reported concurrent in-
tractable physical or social problems which prevented
them from fulfilling their social roles and led to financial
difficulties. This in turn led to stress, which was a barrier
to positive psychological and well-being:
It was bad because I could... my mind could only think
on how to get a job, how to get my daily meal, and my
life was just that way and I went on that way. ID 124,
female, 37 years
Integration of findings
Participants in the intervention arm received more emo-
tional support for themselves and their family, and had
more time to talk about their worries (including spiritual
concerns) and discuss the future. Their families also
received more support with planning. Patients who re-
ceived the intervention also received more weak opioids
(codeine) and laxatives than those allocated to the con-
trol arm. Mental health improvement over the study
period in the intervention group was significantly associ-
ated with receipt of spiritual discussions, paracetamol
and anti-emetics, and negatively associated with receipt
of morphine.
The qualitative and quantitative findings converge
strongly, suggesting that appropriate and effective
medication, effective health education and counselling,
and increased time to talk in clinical encounters are as-
sociated with improvements in psychological well-being.
Barriers to the effectiveness of the intervention were
perceived intractable physical, social or psychological
problems. The importance of holistic care is reflected in
patient descriptions of benefit across physical, psycho-
logical and social domains.
Discussion
This study is an important contribution to our under-
standing of interventions to improve mental health and
long term coping amongst PLWH, and of the value of
mixed method approaches in the evaluation of complex
interventions. Our findings strongly suggest that in-
creased time taken in the structured intervention clinical
encounter enabled the participants to talk about their
problems in a way they had previously been unable to
do. In addition, improved health education meant that
medications were better understood and regimens there-
fore better adhered to.
Whilst effective medication, health education and
counseling, and having time to talk were identified as ac-
tive ingredients of the intervention, it is possible that the
effects of medication and health education and counsel-
ing were mediated by having time to talk. This hypoth-
esis suggests that the intervention offered opportunities
for patients to reflect and gain health information, in-
creasing insight and understanding, as well as to
describe their symptoms in more detail, enabling health-
care providers to prescribe more accurately and effect-
ively and hence provide better symptom relief. Our data
suggested that a structured holistic approach with ad-
equate time to deliver these integrated components is
needed to ensure they are effectively delivered in a
person-centred and participatory way.
Time to talk is often seen as unfeasible in busy clinics
where the number of clients is rising due to the increas-
ing life expectancy of PLWH and earlier initiation of
ART [27]. However, elsewhere, initial evaluation shows
the use of peer mentors, expert clients or other trained
health workers to alleviate common mental disorders
holds promise [28, 29]. This task-shifting approach frees
up nurse contact time, whilst maintaining gains in psy-
chological well-being. On the other hand, initial time to
talk may be a time saving process, even in a busy clinic,
as the benefits might prevent more time-intensive needs
in the future. It is interesting that participants receiving
usual care in this study also reported improvements in
mental health, and attributed this to their interactions
with the researcher [30].
Our findings also highlight the benefits of conducting
mixed-method explorations of process data alongside
RCTs of complex interventions. A sole focus on the
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quantitative outcomes would not have identified the
mechanisms through which the intervention was effect-
ive. The qualitative data also identified further thera-
peutic benefits attributed to the research process itself
[31]. This exemplifies and supports the MRC guidance
on process evaluation as an essential component of the
evaluation of complex interventions [11, 32]. The find-
ings presented here improve our understanding of which
components of this intervention should be implemented
in clinical practice and studied in future research.
A limitation of the study is that it is not possible to clar-
ify from the data the extent to which therapeutic benefit is
attributable to either the content or the duration of the
appointments with the intervention nurses. However, the
qualitative data suggest that they cannot be mutually
exclusive; effective intervention requires a structured
person-centred approach with adequate time for delivery.
There is also potential for our findings to be affected by
recall bias as participants were asked to describe events
from previous months. The exact nature of the discus-
sions that were described as therapeutic by the interven-
tion group and which contributed to the active ingredient
of time to talk is not currently known. While both control
and intervention groups received discussions about pain
and symptoms, only the intervention group described
these discussions as therapeutically beneficial.
Our findings indicate directions for further research to
improve HIV care in resource-constrained settings.
Research should further develop and evaluate sustainable
and feasible models of care for PLWH in these settings,
testing the effects of implementing the active ingredients
we have identified and their applicability in other con-
texts. The effects on retention and adherence to treat-
ment of integrating palliative care into routine services
should also be evaluated. Should the active ingredients
we have found effective be implemented, outcomes
should be compared when it is delivered by staff with
higher and lower qualifications, to evaluate whether it is
in fact time saving in the long term to task shift.
Conclusions
Based on our findings, we recommend a person-centred
approach to routine outpatient care for people on ART,
including implementation of sufficient time to talk, ef-
fective health education and counselling, and access to
appropriate medication for PLWH to manage pain and
symptoms. Integrating time to talk into the clinical
encounter is particularly important given its potential
mediating role, and could be provided by non-medical
staff, in line with recommendations for improving reten-
tion and adherence in HIV care [33]. This model may
enable a more holistic approach to care in resource-
constrained settings and relieve the psychological, phys-
ical and social burden experienced by PLWH.
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